Beginning on June 27, 2023, the DEA requires a one-time attestation of training on management of substance use disorders (SUDs) prior to renewal of a DEA registration.
The DEA has released guidance on the new one-time requirement for completion of eight hours of training on the treatment and management of patients with opioid or other SUDs.
As an ACCME-accredited CME provider with Commendation, ACP offers a wide variety of recommended activities that count toward meeting the new DEA attestation requirement.
Choose from the curated list below to satisfy the completion of a minimum eight hours of substance use disorder CME.
Featured Education
ACP Pain Management 7: Opioid Use Disorder 5 CME
This interactive training module provides background information necessary to support clinicians in their care for persons with opioid use disorder (OUD), including persons with coexisting chronic pain.
Xylazine Adulteration of the Heroin–Fentanyl Drug Supply, A Narrative Review 0.5 CME
Clinical experience along with the available pertinent research were used to review Xylazine, an animal sedative, and provide guidance on the care of patients exposed to Xylazine, published in Annals of Internal Medicine. After reading the article, follow instructions on the Point-of-Care CME page to claim credit.
SUD Presentations from 2023 Internal Medicine Meeting 2.5 CME
Captured from Internal Medicine Meeting 2023, this video bundle package provides 2.5 hours of high-yield video content covering strategies and management options for treating substance use disorder.
X-Express: The ABCs of Prescribing Buprenorphine 1 CME
This highly practical one-hour video course provides an overview of the role buprenorphine plays in the management of opioid use disorder.
Education By Format Type
Additional substance use disorder education can be found in ACP's Online Learning Center.